Catalog Research
Catalog › Repair › BPC-157 + TB-500 20mg
Repair

BPC-157 + TB-500 20mg

BPC-157 + TB-500 20mg — research compound vial

Two of the most studied repair-related compounds combined in one vial. With over 50 published studies between them, this pairing is a reference combination for researchers studying tissue biology.

20mg
$60

How It Works

The Target

Multiple repair pathways — BPC-157 is a 15-amino acid sequence derived from human gastric juice that promotes tissue repair through several parallel mechanisms.

The Mechanism

Upregulates VEGF (vascular endothelial growth factor) to promote new blood vessel formation at injury sites. Activates the FAK-paxillin pathway for cell migration and wound closure. Modulates nitric oxide production and the growth hormone receptor system. Also influences the gut-brain axis through serotonergic and dopaminergic pathways.

Why It Matters

With over 50 published studies, BPC-157 is one of the most extensively studied repair peptides. The multi-pathway mechanism explains its broad activity across different tissue types in research models.

Specifications

Purity>=98% each
MWBPC-157: ~1.4 kDa; TB-500: ~0.9 kDa
FormLyophilized blend
Storage-20 degrees C
ReconstitutionBacteriostatic water
Shelf Life24 months

Published References

review
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (Current reviews in musculoskeletal me... 2025) ↗
clinical
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery (ClinicalTrials.gov Phase 1 2026) ↗
review
Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review (Pharmaceuticals (Basel, Switzerland) 2025) ↗
peer
Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185" (Pharmaceuticals (Basel, Switzerland) 2025) ↗
peer
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185 (Pharmaceuticals (Basel, Switzerland) 2025) ↗
review
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers (Pharmaceutics 2026) ↗

BPC-157 + TB-500 20mg

Third-party verified · batch COAs · US-based fulfillment

View in Catalog →
Research Use Only. BPC-157 + TB-500 20mg is sold exclusively for in vitro laboratory research. It is not a drug, dietary supplement, food, or medical device, and has not been evaluated by the FDA for any purpose. Not for human or veterinary use. NST Research makes no therapeutic, diagnostic, or health claims regarding any compound listed.